Analysis of mortality in Parkinson disease in China: Exploration of recent and future trends

Author:

Lan Jinxin12ORCID,Ren Yifan12ORCID,Song Ge3,Liu Lu4,Li Mingyu5,Zhang Renmu6,Yin Chunyu1,Zhou Hua7,Zhang Xiangyuan1,Lv Bin1ORCID,Ma Yaqi1

Affiliation:

1. The First Medical Center Chinese PLA General Hospital Beijing China

2. School of Medicine Nankai University Tianjin China

3. Department of Health Care 305 Hospital of Chinese PLA Beijing China

4. Taiyuan Wanbailin Medical Group Central Hospital Taiyuan China

5. Department of Internal Medicine Gucheng County Hospital of Traditional Chinese Medicine Hengshui Hebei China

6. Department of Neurology Sinopharm Tongmei General Hospital Datong Shanxi China

7. Department of Neurology Tangshan Hospital of Traditional Chinese Medicine Tangshan Hebei China

Abstract

AbstractObjectivesParkinson disease (PD) is the third leading cause of mortality among middle‐aged and older individuals in China. This study aimed to explore the trends and distribution features of PD mortality in China from 2013 to 2021 and make predictions for the next few decades.MethodsRelevant data were obtained from the Chinese Center for Disease Control and Prevention Disease Surveillance Point system. The joinpoint regression model was used to evaluate trends. The R software was used to predict future trends.ResultsAge‐standardized mortality rate (ASMR) of PD increased from 0.59 per 100,000 individuals to 1.22 per 100,000 individuals from 2013 to 2021, with an average annual percent change (AAPC) of 9.50 (95% CI: 8.24–10.78). The all‐age ASMR of PD were higher in male individuals than in female individuals, and ASMR increased with age. The number of deaths and ASMR increased gradually from west to east and from rural to urban areas. Furthermore, ASMR is expected to increase to 2.66 per 100,000 individuals by 2040.ConclusionsThe heightened focus on the ASMR of PD among male individuals, urban areas, eastern China, and individuals aged ≥85 years has become a key determinant in further decreasing mortality, thereby exhibiting novel challenges to effective strategies for disease prevention and control.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3